We are live on
!
Find out more
Anavex Life Sciences
AVXL
AVXL
59 hedge funds and large institutions have $29.7M invested in Anavex Life Sciences in 2016 Q4 according to their latest regulatory filings, with 13 funds opening new positions, 20 increasing their positions, 11 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
117% more first-time investments, than exits
New positions opened: 13 | Existing positions closed: 6
84% more capital invested
Capital invested by funds: $16.1M → $29.7M (+$13.6M)
82% more repeat investments, than reductions
Existing positions increased: 20 | Existing positions reduced: 11
18.95% more ownership
Funds ownership: 0% → 18.95% (+19%)
11% more funds holding
Funds holding: 53 → 59 (+6)
92% less call options, than puts
Call options by funds: $491K | Put options by funds: $6.04M
Holders
59
Holders Change
+6
Holders Change %
+11.32%
% of All Funds
1.48%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.03%
New
13
Increased
20
Reduced
11
Closed
6
Calls
$491K
Puts
$6.04M
Net Calls
-$5.54M
Net Calls Change
-$4.42M
Top Buyers
Top Sellers
| 1 |
D.E. Shaw & Co
New York
|
-$434K |
| 2 |
Bank of Montreal
Toronto,
Ontario, Canada
|
-$129K |
| 3 |
Tudor Investment Corp
Stamford,
Connecticut
|
-$75K |
| 4 |
Millennium Management
New York
|
-$73K |
| 5 |
CS
Credit Suisse
Zurich,
Switzerland
|
-$60.3K |
